Do not centriuge or freeze
Lipoprotein(a) (Lp(a)) is a plasma lipoprotein which consists of an apo(B) containing LDL-like particle covalently linked to a large glycoprotein, apo(a). Elevated plasma concentrations of Lp(a) are a risk factor for coronary heart disease, cerebrovascular disease, atherosclerosis, thrombosis and stroke. Apo(a) is encoded by the LPA gene with variation in the LPA gene accounting for around 90% of the variation in Lp(a) levels with size of the genetically determined Kringle 4 type 2 (KIV-2) repeat in the LPA gene affecting the size of the apo(a) protein.
Small numbers of KIV-2 repeats, and hence small isoforms of apo(a), are associated with an increased risk of CVD and atherosclerosis and can give erroneously low levels of Lp(a) when measured on some assays.
This assay will determine the number of KIV-2 repeats via qPCR and will also determine the presence of absence of two SNPs, rs10455872 and rs3798220, which are associated with an increased odds ratios for CAD.
For more information, please see the links to the publicaitons below.
No preperation required.
Test will not be performed without a completed patient consent form and permission from the relevent consultant.
Please only place samples for Lp(a) genotyping in the CSU pot if it is clearly indicated on the request form (e.g. LIPOA GENOTYPING). All samples for immunochemical measurement of Lp(a) DO NOT require Lp(a) genotyping.
Any questions please contact Dr Alex Lawson on 43235 or the duty biochemist on bleep 2506
Interpretative comments will be attached to report.
Copyright heftpathology 2013, 2014, 2015, 2016, 2017, 2018
HTA licence number is 12366
Protection of Personal Information – Laboratory Medicine comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.
The Trust Laboratories at Heartlands Hospital, Good Hope Hospital and Solihull Hospital were awarded UKAS (United Kingdom Accreditation Service) accreditation to the internationally recognised ISO 15189 standard in May 2015. For a list of accredited tests and other information please visit the test database http://www.heftpathology.com/frontpage/test-database.html.
Tests not appearing on this scope are either under consideration or in the process of accreditation and so currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.
For further information contact Louise Fallon, Quality Manager, 0121 424 1235